# Belotecan and Cisplatin in Treating Patients With Previously Untreated, Extensive-Stage Small Cell Lung Cancer

> **NCT00754858** · PHASE2 · COMPLETED · sponsor: **Yonsei University** · enrollment: 42 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** belotecan hydrochloride
- **DRUG:** cisplatin

## Key facts

- **NCT ID:** NCT00754858
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2010-05
- **Final completion:** 2012-06
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2014-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00754858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00754858, "Belotecan and Cisplatin in Treating Patients With Previously Untreated, Extensive-Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00754858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*